{"id":2880,"name":"MedTech Collective","slug":"medtech-collective","website":"https://medtechcollective.com/","hqGeo":"Boston, MA","stageFocus":["Seed"],"sectorTags":["Healthcare","Other","AI / ML"],"excludedSectors":["Consumer","Hardware-heavy biotech"],"checkSizeMin":100000,"checkSizeMax":1000000,"thesisSummary":"Focused exclusively on investing in startups innovating within the healthcare tech stack, including pharmaceutical automation technologies.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"BioBridge AI","companyUrl":null,"stage":null,"sector":"PharmaTech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Automated Clinics","companyUrl":null,"stage":null,"sector":"HealthTech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pleural Dynamics","companyUrl":null,"stage":"Early / development stage","sector":"Medical device / respiratory / pulmonary interventions","investmentYear":null,"description":"Develops the Automatic Continuous Effusion Shunt system for managing pleural effusions and refractory ascites (fluid buildup in lung cavities, abdomen).","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MadSci (Madison Scientific Inc.)","companyUrl":null,"stage":"Seed / development stage","sector":"Neurosurgery / neurosurgical device / implantable shunt technology","investmentYear":null,"description":"A development-stage company creating an integrated implantable SmartShunt system to optimize treatment for hydrocephalus patients (ventricular fluid pressure relief).","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aliform","companyUrl":null,"stage":"Seed / early clinical usage","sector":"Aesthetic surgery / subcutaneous device","investmentYear":null,"description":"Focused on minimally invasive aesthetic-surgery technologies, especially a device (“Celluleaf”) for septae release under the skin to treat cellulite.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Moonrise Medical","companyUrl":null,"stage":"Early stage, pre-commercial or early commercial trials","sector":"Imaging / diagnostic / AI-augmented ultrasound","investmentYear":null,"description":"AI-enabled ultrasound imaging system aimed to simplify vascular diagnostics and enable earlier detection of peripheral artery disease to reduce amputations.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Embolx","companyUrl":null,"stage":"Commercial (or near commercial) stage","sector":"Interventional radiology / vascular devices","investmentYear":null,"description":"A commercial-stage device company in Silicon Valley developing microcatheters for arterial embolization procedures.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Atraverse Medical","companyUrl":null,"stage":"Early / pre-market (engineering / regulatory)","sector":"Structural heart / catheter-based interventional devices","investmentYear":null,"description":"Developing flexible transseptal left-heart access technologies; its “Hotwire” system aims for better safety, visibility & workflow in procedures requiring transseptal access.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Theromics Inc.","companyUrl":null,"stage":"Early clinical / development stage","sector":"Ablation / electrosurgery / thermal therapy","investmentYear":null,"description":"Working on next-generation thermal accelerant technology for enhanced ablation procedures and more precise delivery of ablative or therapeutic energy.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"FormaPath","companyUrl":null,"stage":"Seed / early clinical deployment","sector":"Robotics / digital pathology / lab automation","investmentYear":null,"description":"Robotic & AI-equipped tools to automate pathology workflows; robotics + digital pathology to improve consistency and throughput.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Polyembo","companyUrl":null,"stage":"Development / early clinical stage","sector":"Vascular device / embolic agents / structural & neurovascular","investmentYear":null,"description":"Creates advanced embolic technologies (SCRUNCHY & SPHERE products) to address unmet needs in peripheral vascular, structural heart, and neurovascular spaces (vessel occlusion).","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CardiaCare","companyUrl":null,"stage":"Early stage / proof-of-concept","sector":"Cardiac rhythm / neuromodulation / digital health + devices","investmentYear":null,"description":"Non-invasive electrical neuromodulation applied at the wrist for atrial fibrillation care; aims to reduce episodes & symptoms via wearable or minimally invasive tech.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neuronoff","companyUrl":null,"stage":"Pre-clinical / early development","sector":"Neuromodulation / implantable devices","investmentYear":null,"description":"The “Injectrode™” platform intends to simplify neuromodulation treatments, making them more accessible for patients with chronic conditions via injectable soft electrode technology.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Sinaptica Therapeutics","companyUrl":null,"stage":"Early stage / pre-clinical or early clinical trials","sector":"Neurology / neuroscience / noninvasive therapy","investmentYear":null,"description":"Personalized, noninvasive neuromodulation therapies aimed at slowing progression of Alzheimer’s disease.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":1,"partners":[{"id":19966,"name":"Kat Hurd","title":"Founder","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/kat-hurd","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":13023,"name":"Volition Capital Fund","slug":"volition-capital-fund","logoUrl":null,"website":"https://www.volitioncapital.com/","stageFocus":["Pre-Seed"],"sectorTags":["SaaS","AI / ML","Developer Tools","Other","Security"],"hqGeo":"Boston, MA"},{"id":13350,"name":"AI-Finspace Ventures","slug":"ai-finspace-ventures","logoUrl":null,"website":null,"stageFocus":["Seed"],"sectorTags":["Fintech","AI / ML","Healthcare","SaaS"],"hqGeo":"New York, NY"},{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":13762,"name":"NeuroNet Ventures","slug":"neuronet-ventures","logoUrl":null,"website":"https://neuronetgpo.com/","stageFocus":["Seed"],"sectorTags":["AI / ML","Other"],"hqGeo":"Chicago, IL"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Other","Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":10388,"name":"Africa Tech Ventures","slug":"africa-tech-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","AI / ML","Food / AgTech","Consumer","Fintech","EdTech"],"hqGeo":"Nairobi, Kenya"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-05-18T05:46:33.670Z"}